Latest News

Clinical trial: Promising drug slows brain shrinkage in progressive MS patients

A promising drug slowed brain shrinkage in progressive multiple sclerosis (MS) by nearly half, according to new research led by Cleveland Clinic. Very limited therapies are currently available for this disabling form of the disease.

Source link

Related posts

An Athlete’s Body Could Offer Potential Supplement To Make Lazy People Active


Study estimates use of cigarettes, e-cigarettes among women of reproductive age in the U.S.


UChicago Medicine installs hands-only CPR kiosk in the Center for Care and Discovery


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy